Lucid Diagnostics LUCD Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -1,054.8%+4.8pp | -1,059.7%+937pp | -1,996.8%+12,924pp | -14,920.7%— | |
| Net margin | -1,232.7%-185pp | -1,047.6%+1,122pp | -2,169.1%+12,730pp | -14,899.5%— | |
| Returns | |||||
| Return on equity | -710.6%— | —— | —— | -144.4%— | |
| Efficiency | |||||
| Asset turnover | 0.1×0.0× | 0.1×+0.1× | 0.1×+0.1× | 0×— | |
| Liquidity | |||||
| Current ratio | 1.3×+0.2× | 1.1×+0.3× | 0.8×-2.1× | 2.9×-10.6× | |
| Leverage | |||||
| Debt-to-equity | 0.2×-0.3× | 0.5×— | —— | 0.1×— | |
| Valuation | |||||
| Market capitalization | $204.13M+58.5% | $48.58M-18.6% | $59.69M+17.5% | $50.78M-73.1% | |
| Price / sales | 39.8×+10.2× | 11.2×-13.4× | 24.6×-110× | 134.7×— | |
| Price / book | 51×+34.7× | 9×— | —— | 2.2×-1.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Lucid Diagnostics's profit margins?
- Lucid Diagnostics (LUCD) runs a -66.8% gross margin and a -959.6% operating margin, with a -876.7% net margin.
- Where do Lucid Diagnostics's ratios come from?
- Every ratio is computed from Lucid Diagnostics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
